Oral roflumilast showed potential as a nonbiologic systemic therapy for moderate to severe psoriasis, offering an alternative ...

Complete clearance lasts for a very long time due to knockout of resident memory T cells within the skin,’ said the study’s ...

SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Positive Results for SGX302 in Cohort 3 of Phase 2a Psoriasis Trial ...

The treatment of psoriasis—an autoimmune disease that creates red, scaly plaques on the skin—depends on multiple factors, but two big factors include the severity and the location of the symptoms, ...

Back in October, the 2025 Fall Clinical Dermatology Conference showcased some of the most exciting advances in skin disease treatment this year. From pill-based TYK2 inhibitors and durable IL-23 ...

The results position Takeda, which acquired its therapy in one of the industry’s larger single-drug acquisitions, to ...

Please provide your email address to receive an email when new articles are posted on . The LITE study compared at-home and in-office phototherapy in more than 750 patients with psoriasis across all ...

Psoriasis is a chronic autoimmune skin condition causing red, scaly patches. It can appear on various body parts, including the scalp, elbows, knees, hands, feet, lower back, torso, face, and ...

Phototherapy is the oldest form of psoriasis therapy and is still likely the most commonly used. From prescribing exposure to various wavelengths of ultraviolet light, to applying salts and tars at ...

Bruce Sherman, MD, FCCP, FACOEM, explores how to improve treatment for psoriasis and education surrounding diagnosing psoriasis for all skin phototypes. Ryan Haumschild, PharmD, MS, MBA: Biologic ...

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Extends Pediatric Psoriasis Study: What ...

Compared to Sotyktu (deucravacitinib), which was approved by the FDA for plaque psoriasis in 2022 and brought in sales of ...